17 research outputs found

    DEVELOPMENT AND VALIDATION OF THE TAIWAN CHILDREN’S ENVIRONMENTAL ACTION INDEX

    Get PDF
    In this study, we use Smith-Sebasto & Fortner’s (1994) Environmental Action Internal Control Index (EAICI) as a framework to develop, and validate a useful instrument for assessing environmental attitudes and behavior among elementary and middle school children within the Taiwanese context. We dub the new instrument the Taiwan Children’s Environmental Action Index (TCEAI). Our findings suggest that the TCEAI displays substantial internal consistency (Cronbach's alpha=.92), moderately positive correlations with self-report measures of environmentally responsible behavior (R = .35 to .46, p < .01), and few threats to validity by age or gender. The results suggest that the TCEAI may be used to elicit important dimensions of environmental attitudes and to predict environmentally responsible behavior for elementary and middle school children in Taiwan. Practical implications are discussed

    Perplexing Associations

    No full text

    A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada

    Get PDF
    Canada needs a national strategy to fulfill its obligation to ensure universal access to necessary healthcare, including prescription drugs. A 2004 attempt at a national strategy for pharmaceutical policy failed because it lacked clear vision, logical planning and commitment from federal and provincial governments. The result of uncoordinated pharmaceutical policies in Canada has been more than a decade of poor system performance. In this essay, we present a framework for a renewed national strategy for pharmaceutical policy. Building on published research and international frameworks, we propose that pharmaceutical policies of federal, provincial and territorial governments be coordinated around a core health-focused goal. We strongly suggest policy actions be taken on four core objectives that are necessary to support the overarching health goal. If implemented, the proposed strategy would offer clear benefits to all Canadians who use medicines, federal and provincial governments and to the economy as a whole. We therefore argue that political leadership is now needed to articulate and implement such a plan on behalf of Canadians
    corecore